ICD 10 CM D68.6 | Description & Clinical Information

ICD 10 D68.6 describes a medical condition known as thrombophilia, which is characterized by a blood disorder that increases the likelihood of blood clotting in the blood vessels due to low levels of antithrombin III in the blood, leading to an elevated risk of blood clot formation, and is used when the provider documents a type of thrombophilia that is not represented by another code.

Official Description Of D68.6

The ICD 10 CM book defines ICD 10 code D68.6 as:

Other thrombophilia
Other hypercoagulable states
Excludes1: diffuse or disseminated intravascular coagulation [DIC] (D65)
heparin induced thrombocytopenia (HIT) (D75.82-)
hyperhomocysteinemia (E72.11)
Parent Code Notes: D68

Excludes1: abnormal coagulation profile NOS (R79.1)

Excludes2: coagulation defects complicating abortion or ectopic or molar pregnancy (O00-O07, O08.1)
coagulation defects complicating pregnancy, childbirth and the puerperium (O45.0, O46.0, O67.0, O72.3)

When To Use D68.6

The diagnosis describes by the ICD 10 CM D68.6 code is known as thrombophilia. This condition occurs due to excessive blood clotting in the body, potentially leading to various health issues. Some patients with thrombophilia may not display any symptoms until they experience complications related to poor blood circulation, while others may experience deep vein thrombosis characterized by swelling, pain, and redness around the affected area, or pulmonary embolism that can cause breathing difficulties, lethargy, fainting, and headaches.

Medical providers typically diagnose thrombophilia by evaluating a patient’s medical history, symptoms, and performing a physical examination. Laboratory tests such as a complete blood count (CBC) are often used to measure platelet count, prothrombin time (PT), thrombin clotting time (TCT), fibrinogen degradation products, and partial thromboplastin time (PTT).

The severity of thrombophilia can vary, and treatment options depend on the cause and severity of the disease. While there is currently no known cure for primary thrombophilia, anticoagulant medications like heparin, warfarin, and aspirin can help manage symptoms and prevent complications, such as pulmonary embolism and deep vein thrombosis, from developing.

It is essential for patients diagnosed with thrombophilia to understand the condition thoroughly, including the potential risks of developing complications, which can lead to severe health issues if left untreated. Additionally, individuals with a family history of thrombophilia or recurring blood clots should consult with their healthcare providers to determine if the condition is hereditary and to take preventative measures.

In conclusion, ICD 10 CM D68.6, or thrombophilia, can pose severe health risks if not adequately managed. Therefore, it is crucial to work closely with medical providers in monitoring the condition and follow prescribed treatment plans, which may include medications and lifestyle changes. By doing so, individuals with thrombophilia can greatly reduce their risk of developing complications and improve their overall quality of life.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *